Publication Month: Mar 2022 | Report Code: TIPRE00008772 | No. of Pages: 173 | Category: Medical Device | Status: Published
|Market Size Value in||US$ 6,970.97 Million in 2021|
|Market Size Value by||US$ 13,816.53 Million by 2028|
|Growth rate||CAGR of 10.3% from 2021 to 2028|
|No. of Pages||173|
|No. of Tables||84|
|No. of Charts & Figures||76|
|Historical data available||Yes|
|Segments covered||Product, Procedure, and Type|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
On the other hand, product recalls associated with custom procedure kits negatively impact the overall market growth. For example, in November 2021, the US Food and Drug Administration (USFDA) reported that Aligned Medical Solutions announced its custom procedure kits product recall. The FDA identified the recall as a Class 1 recall considered one of the most severe types of recall. Furthermore, Cardinal Health with the USFDA announced initiating two voluntary field actions for "Cardinal Health Presource Procedure Packs" in January 2020. These packs contain gowns called for product recalls and kept for voluntary hold. These factors are responsible for the sluggish growth of the custom procedure kits market over the coming years.
North America is likely to continue its dominance in the custom procedure kits market between 2021 and 2028. The US held the largest market share in this region in 2021, owing mainly to the growing awareness of aesthetic appearance and cosmetic surgeries performed at a larger scale in the US alone. For records, the International Society of Aesthetic Plastic Surgery (ISAPS) reported that breast procedures, body & extremities procedures, and face & head procedures accounted for 40.2%, 37.8%, and 22.0%, respectively, of the overall aesthetic surgeries performed in the US in 2020. Moreover, the same year, the US gained the first position in the total number of aesthetic procedures performed, accounting for 19.0%.
On the other hand, Asia Pacific is expected to witness lucrative growth over the forecast period. Advanced designs of custom graphic trays and sterilization trays to optimize operation theatre workflows in hospital settings and clinics have resulted in a higher demand for custom procedure kits in the regional market, and this trend is expected to continue over the coming years.
The custom procedure kits can save hospital time before, during, and after surgery by cutting preparation time and making it easier to remove waste. Additionally, custom procedure packs can reduce the amount of waste generated in units. For example, the Kingston Hospital witnessed the number of clinical waste bags reducing by 50%, and an initiative taken by the Royal Liverpool and Broadgreen University Hospitals found that utilizing custom procedure kits allows them to eliminate one load of waste per procedure. The Practice Greenhealth report states that a number of mechanisms can be used to reduce waste creation. Examples include strategies for streamlining supply, standardizing custom procedure kits supply, and others. Also, using custom procedure packs allows healthcare providers to work more efficiently and potentially deliver higher quality healthcare and maintain sustainability and green management across the overall healthcare sector. These factors are boosting the uptake of custom procedure kits at a large scale, ultimately stimulating the overall market growth during the forecast period.
Based on product type, the custom procedure kits market has been divided into disposable and reusable. The disposable segment is estimated to account for a larger market share from 2021 to 2028. The rising need for cost-efficiency has led to an increased focus on utilizing single-use and disposable products. Disposable items are majorly packaged in the custom procedure packs as it eliminates the need for the problems of sterilization units at hospitals. Additionally, all healthcare-related providers are responsible for preventing and controlling Healthcare-Associated Infections (HAIs). Adopting disposable items in custom procedure kits is a huge step in the right direction, straightforward, cost-effective, and time-effective for handling infection transmission and prevention among the hospital patient population. These factors are expected to positively influence the segment, eventually contributing to the custom procedure kits market over the forthcoming years.
Companies operating in the custom procedure kits market adopt the product innovation strategy to meet the evolving customer demands worldwide, permitting them to maintain their brand name in the global market.
Based on product type, the custom procedure kits market has been bifurcated into disposable and reusable. By procedure, the market has been segmented into bariatric, colorectal, thoracic, orthopedic, ophthalmology, spine surgery, cardiac surgery, and others. Based on type, the market has been bifurcated into sterile and non-sterile. Based on geography, the market has been primarily segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America (SCAM). The market in North America has been further segmented into the US, Canada, and Mexico. The European custom procedure kits market has been segmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The market in Asia Pacific has been segmented into China, India, Japan, Australia, South Korea, and the Rest of APAC. The custom procedure kits market in the MEA has been segmented into Saudi Arabia, the UAE, South Africa, and the Rest of MEA. The market in South and Central America has been segmented into Brazil, Argentina, and the Rest of South and Central America.
Some leading companies operating in the custom procedure kits market are Medline Industries, Inc.; Teleflex Incorporated; Owens & Minor Inc.; Medtronic; Cardinal Health Inc.; McKesson Corporation; Smith's Medical; Terumo Cardiovascular Systems Corporation; CPT Medical; and OneMed.